14 juli 2021: Bron: 2021 Apr; 13(4): 1241

Uit een 18 jaar durende studie blijkt dat dagelijks een kop koffie de kans op overlijden door alle oorzaken met 27% kan verminderen. Bij meer dan 1 kopje was dat zelfs 44%. Uit eerdere onderzoekers blijkt dat deze resultaten in overeenstemming zijn met wat eerder is gevonden. Zie ook paar artikelen op onze site daarover.

Waarom koffie zo goed zou zijn is nog niet duidelijk. Onderzoekers denken dat dit komt omdat koffie veel antioxidanten bevat of een gunstig effect op het microbioom van de darmen heeft. Uit dit recente onderzoek blijkt wel dat je ook weer niet teveel koffie moet drinken want al bij dagelijks 3 – 4 koppen koffie blijkt het geen voordeel meer op te leveren maar eerder een nadeel. De hoeveelheid ligt dus wel gevoelig.

De onderzoekers gebruikten gegevens over koffieconsumptie en andere persoonlijke variabelen, en het aantal sterfgevallen gedurende een follow-up periode van 18 jaar, voor 1567 deelnemers van 20 jaar en ouder uit de Valencia Nutrition Study in Spanje.

De totale consumptie van koffie, cafeïnehoudende koffie en cafeïnevrije koffie werd bepaald met behulp van een erkende voedselfrequentievragenlijst. Gedurende de 18-jarige follow-up periode overleden 317 personen, waarvan 115 aan hart- en vaatziektes en 82 aan kanker. Vergeleken met geen consumptie, was de consumptie van dagelijks 1 kop koffie en meer dan 1 kop koffie per dag geassocieerd met een lager risico van sterfte aan alle oorzaken, HR = 0,73 (95% CI: 0,56-0,97) en HR 0,56 (95% CI: 0,41-0,77), respectievelijk.

Een lagere kankersterfte werd waargenomen bij drinkers van meer dan 1 kopje per dag vergeleken met niet-drinkers, HR 0,41 (95% CI 0,20-0,86). Wat het type koffie betreft, was alleen de algemene consumptie van cafeïnehoudende koffie geassocieerd met een lagere sterfte aan alle oorzaken na 12 en 18 jaar follow-up, HR = 0,66 (95% CI: 0,46-0,94) en HR = 0,59 (95% CI: 0,44-0,79), respectievelijk.

Conclusie van de onderzoekers:

Deze studie suggereert dat een matige consumptie van koffie, met name van cafeïnehoudende koffie geassocieerd is met een lagere sterfte aan alle oorzaken en kanker na een lange follow-up periode. (bereik 1-6,5 kopjes per dag)

Het studierapport is gratis in te zien. Hier het abstract van de studie:

2021 Apr; 13(4): 1241.

Published online 2021 Apr 9. doi: 10.3390/nu13041241

PMCID: PMC8070495

PMID: 33918797

Coffee Consumption and All-Cause, Cardiovascular, and Cancer Mortality in an Adult Mediterranean Population

Laura Torres-Collado,1,2,3 Laura María Compañ-Gabucio,1,2,3 Sandra González-Palacios,1,2,3 Leyre Notario-Barandiaran,1,2,3 Alejandro Oncina-Cánovas,1,2,3 Jesús Vioque,1,2,3,* and Manuela García-de la Hera1,2,3

Stefano Realdon, Academic Editor

Author information Article notes Copyright and License information Disclaimer

Associated Data

Data Availability Statement

Abstract

We assessed the association between usual coffee consumption and all-cause, cardiovascular (CV), and cancer mortality in an adult population in Spain, taking into account both the amount and type of coffee consumed. We used baseline data on coffee consumption and other personal variables, and the number of deaths during an 18-year follow-up period, for 1567 participants aged 20 years and older from the Valencia Nutrition Study in Spain. Total, caffeinated, and decaffeinated coffee consumption was assessed using a validated food frequency questionnaire. Cox regression models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). During the 18-year follow-up period, 317 died; 115 due to CV disease and 82 due to cancer. Compared with no-consumption, the consumption of ≤1 cup per day and >1 cup per day of coffee was associated with a lower risk of all-cause mortality, HR = 0.73 (95% CI: 0.56–0.97) and HR 0.56 (95% CI: 0.41–0.77), respectively. A lower cancer mortality was observed among drinkers of more than 1 cup per day compared with nondrinkers, HR 0.41 (95% CI 0.20–0.86). Regarding the type of coffee, only the overall consumption of caffeinated coffee was associated with lower all-cause mortality at 12 and 18 years of follow-up, HR = 0.66 (95% CI:0.46–0.94) and HR = 0.59 (95% CI: 0.44–0.79), respectively.

In conclusion, this study suggests that the moderate consumption of coffee, particularly caffeinated coffee (range 1–6.5 cups per day), is associated with a lower all-cause and cancer mortality after a long follow-up period. No significant association was found between coffee consumption and CVD mortality.

5. Conclusions

In conclusion, this study suggests that the moderate consumption of coffee, particularly caffeinated coffee (range 1–6.5 cups per day), is associated with a lower all-cause and cancer mortality after a long follow-up period. These findings are consistent with previous studies, although they add new evidence from a Mediterranean adult population. Thus, coffee consumption could be promoted as part of a healthy Mediterranean lifestyle, although further long-term longitudinal studies collecting information on the amount and type of coffee should add valuable information regarding its beneficial effects.

Go to:

Acknowledgments

The authors thank the VNS participants for their valuable contribution to this research. We appreciate the English revision of the manuscript made by Jessica Gorlin.

Go to:

Author Contributions

Conceptualization, J.V. and M.G.-d.l.H.; formal analysis, L.T.-C.; data curation, L.T.-C. and J.V.; writing—original draft preparation, L.T.-C.; writing—review and editing, L.T.-C., L.M.C.-G., S.G.-P., L.N.-B., and A.O.-C.; supervision, J.V. and M.G.-d.l.H. All authors have read and agreed to the published version of the manuscript.

Go to:

Funding

The VNS study was supported by a grant from the Dirección General de Salud Pública, Generalitat Valenciana 1994 and the Fondo Investigacion Sanitaria (FIS 00/0985). This study has also received support from the Instituto de Salud Carlos III and FEDER funds (FIS PI13/00654).

Go to:

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the local Ethical Committees of the Hospital of San Juan and the Miguel Hernandez University.

Go to:

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Go to:

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to confidentiality and ethical reasons.

Go to:

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Go to:

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Go to:

References

1. Kim Y., Je Y., Giovannucci E. Coffee Consumption and All-Cause and Cause-Specific Mortality: A Meta-Analysis by Potential Modifiers. Eur. J. Epidemiol. 2019 doi: 10.1007/s10654-019-00524-3. [PubMed] [CrossRef] [Google Scholar]

2. Cai L., Ma D., Zhang Y., Liu Z., Wang P. The Effect of Coffee Consumption on Serum Lipids: A Meta-Analysis of Randomized Controlled Trials. Eur. J. Clin. Nutr. 2012;66:872–877. doi: 10.1038/ejcn.2012.68. [PubMed] [CrossRef] [Google Scholar]

3. Higdon J.V., Frei B. Coffee and Health: A Review of Recent Human Research. Crit. Rev. Food Sci. Nutr. 2006;46:101–123. doi: 10.1080/10408390500400009. [PubMed] [CrossRef] [Google Scholar]

4. Palatini P., Fania C., Mos L., Garavelli G., Mazzer A., Cozzio S., Saladini F., Casiglia E. Coffee Consumption and Risk of Cardiovascular Events in Hypertensive Patients. Results from the HARVEST. Int. J. Cardiol. 2016;212:131–137. doi: 10.1016/j.ijcard.2016.03.006. [PubMed] [CrossRef] [Google Scholar]

5. Liu J., Sui X., Lavie C.J., Hebert J.R., Earnest C.P., Zhang J., Blair S.N. Association of Coffee Consumption with All-Cause and Cardiovascular Disease Mortality. Mayo Clin. Proc. 2013;88:1066–1074. doi: 10.1016/j.mayocp.2013.06.020. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

6. Ding M., Bhupathiraju S.N., Chen M., van Dam R.M., Hu F.B. Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-Analysis. Diabetes Care. 2014;37:569–586. doi: 10.2337/dc13-1203. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

7. Santos R.M.M., Lima D.R.A. Coffee Consumption, Obesity and Type 2 Diabetes: A Mini-Review. Eur. J. Nutr. 2016;55:1345–1358. doi: 10.1007/s00394-016-1206-0. [PubMed] [CrossRef] [Google Scholar]

8. Wu L., Sun D., He Y. Coffee Intake and the Incident Risk of Cognitive Disorders: A Dose-Response Meta-Analysis of Nine Prospective Cohort Studies. Clin. Nutr. 2017;36:730–736. doi: 10.1016/j.clnu.2016.05.015. [PubMed] [CrossRef] [Google Scholar]

9. Liu Q.-P., Wu Y.-F., Cheng H.-Y., Xia T., Ding H., Wang H., Wang Z.-M., Xu Y. Habitual Coffee Consumption and Risk of Cognitive Decline/Dementia: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Nutrition. 2016;32:628–636. doi: 10.1016/j.nut.2015.11.015. [PubMed] [CrossRef] [Google Scholar]

10. Grosso G., Godos J., Galvano F., Giovannucci E.L. Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annu. Rev. Nutr. 2017;37:131–156. doi: 10.1146/annurev-nutr-071816-064941. [PubMed] [CrossRef] [Google Scholar]

11. Poole R., Kennedy O.J., Roderick P., Fallowfield J.A., Hayes P.C., Parkes J. Coffee Consumption and Health: Umbrella Review of Meta-Analyses of Multiple Health Outcomes. BMJ. 2017;359:5024. doi: 10.1136/bmj.j5024. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

12. Ding M., Satija A., Bhupathiraju S.N., Hu Y., Sun Q., Han J., Lopez-Garcia E., Willett W., Dam R.M.v., Hu F.B. Association of Coffee Consumption with Total and Cause-Specific Mortality in Three Large Prospective Cohorts. Circulation. 2015;132:2305–2315. doi: 10.1161/CIRCULATIONAHA.115.017341. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

13. Bravi F., Tavani A., Bosetti C., Boffetta P., La Vecchia C. Coffee and the Risk of Hepatocellular Carcinoma and Chronic Liver Disease: A Systematic Review and Meta-Analysis of Prospective Studies. Eur. J. Cancer Prev. 2017;26:368–377. doi: 10.1097/CEJ.0000000000000252. [PubMed] [CrossRef] [Google Scholar]

14. Caini S., Cattaruzza S., Bendinelli B., Tosti G., Masala G., Gnagnarella P., Assedi M., Stanganelli I., Palli D., Gandini S. Coffee, Tea and Caffeine Intake and the Risk of Non-Melanoma Skin Cancer: A Review of the Literature and Meta-Analysis. Eur. J. Nutr. 2016;56:1–12. doi: 10.1007/s00394-016-1253-6. [PubMed] [CrossRef] [Google Scholar]

15. Grosso G., Micek A., Godos J., Pajak A., Sciacca S., Galvano F., Giovannucci E.L. Dietary Flavonoid and Lignan Intake and Mortality in Prospective Cohort Studies: Systematic Review and Dose-Response Meta-Analysis. Am. J. Epidemiol. 2017;185:1304–1316. doi: 10.1093/aje/kww207. [PubMed] [CrossRef] [Google Scholar]

16. Ludwig I.A., Clifford M.N., Lean M.E.J., Ashihara H., Crozier A. Coffee: Biochemistry and Potential Impact on Health. Food Funct. 2014;5:1695–1717. doi: 10.1039/C4FO00042K. [PubMed] [CrossRef] [Google Scholar]

17. Torres-Collado L., Garcia-de-la-Hera M., Navarrete-Muñoz E.M., Notario-Barandiaran L., Gonzalez-Palacios S., Zurriaga O., Melchor I., Vioque J. Coffee Consumption and Mortality from All Causes of Death, Cardiovascular Disease and Cancer in an Elderly Spanish Population. Eur. J. Nutr. 2018 doi: 10.1007/s00394-018-1796-9. [PubMed] [CrossRef] [Google Scholar]

18. Navarro A.M., Martinez-Gonzalez M.Á., Gea A., Grosso G., Martín-Moreno J.M., Lopez-Garcia E., Martin-Calvo N., Toledo E. Coffee Consumption and Total Mortality in a Mediterranean Prospective Cohort. Am. J. Clin. Nutr. 2018;108:1113–1120. doi: 10.1093/ajcn/nqy198. [PubMed] [CrossRef] [Google Scholar]

19. Ruggiero E., Di Castelnuovo A., Costanzo S., Persichillo M., De Curtis A., Cerletti C., Donati M.B., de Gaetano G., Iacoviello L., Bonaccio M., et al. Daily Coffee Drinking Is Associated with Lower Risks of Cardiovascular and Total Mortality in a General Italian Population: Results from the Moli-Sani Study. J. Nutr. 2021;151:395–404. doi: 10.1093/jn/nxaa365. [PubMed] [CrossRef] [Google Scholar]

20. Quiles J., Vioque J. Prevalence of obesity in the Valencian community. Med. Clin. 1998;110:319. [PubMed] [Google Scholar]

21. Willett W.C., Sampson L., Stampfer M.J., Rosner B., Bain C., Witschi J., Hennekens C.H., Speizer F.E. Reproducibility and Validity of a Semiquantitative Food Frequency Questionnaire. Am. J. Epidemiol. 1985;122:51–65. doi: 10.1093/oxfordjournals.aje.a114086. [PubMed] [CrossRef] [Google Scholar]

22. Vioque J., González L. Validity of a Food Frequency Questionnaire (Preliminary Results) Eur. J. Cancer Prev. 1991;1:19–20. doi: 10.1097/00008469-199110001-00029. [CrossRef] [Google Scholar]

23. Buckland G., González C.A., Agudo A., Vilardell M., Berenguer A., Amiano P., Ardanaz E., Arriola L., Barricarte A., Basterretxea M., et al. Adherence to the Mediterranean Diet and Risk of Coronary Heart Disease in the Spanish EPIC Cohort Study. Am. J. Epidemiol. 2009;170:1518–1529. doi: 10.1093/aje/kwp282. [PubMed] [CrossRef] [Google Scholar]

24. Trichopoulou A., Kouris-Blazos A., Wahlqvist M.L., Gnardellis C., Lagiou P., Polychronopoulos E., Vassilakou T., Lipworth L., Trichopoulos D. Diet and Overall Survival in Elderly People. BMJ. 1995;311:1457–1460. doi: 10.1136/bmj.311.7018.1457. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

25. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. Adherence to a Mediterranean Diet and Survival in a Greek Population. N. Engl. J. Med. 2003;348:2599–2608. doi: 10.1056/NEJMoa025039. [PubMed] [CrossRef] [Google Scholar]

26. U.S. Department of Agriculture ARS. USDA Nutrient Data Laboratory . USDA National Nutrient Database for Standard Reference. Washington, DC, USA: 2008. Release 23. [Google Scholar]

27. Palma I., Farran A., Cantós D. Tablas de Composición de Alimentos Por Medidas Caseras de Consumo Habitual En España. Centre d’Ensenyament Superior de Nutrició i Dietética (CESNID) Mc Graw-Hill Interamericana; Madrid, Spain: 2008. [Google Scholar]

28. Lean M.E., Han T.S., Morrison C.E. Waist Circumference as a Measure for Indicating Need for Weight Management. BMJ. 1995;311:158–161. doi: 10.1136/bmj.311.6998.158. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

29. Bush T.L., Miller S.R., Golden A.L., Hale W.E. Self-Report and Medical Record Report Agreement of Selected Medical Conditions in the Elderly. Am. J. Public Health. 1989;79:1554–1556. doi: 10.2105/AJPH.79.11.1554. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

30. Harlow S.D., Linet M.S. Agreement between Questionnaire Data and Medical Records. The Evidence for Accuracy of Recall. Am. J. Epidemiol. 1989;129:233–248. doi: 10.1093/oxfordjournals.aje.a115129. [PubMed] [CrossRef] [Google Scholar]

31. Malerba S., Turati F., Galeone C., Pelucchi C., Verga F., La Vecchia C., Tavani A. A Meta-Analysis of Prospective Studies of Coffee Consumption and Mortality for All Causes, Cancers and Cardiovascular Diseases. Eur. J. Epidemiol. 2013;28:527–539. doi: 10.1007/s10654-013-9834-7. [PubMed] [CrossRef] [Google Scholar]

32. Crippa A., Discacciati A., Larsson S.C., Wolk A., Orsini N. Coffee Consumption and Mortality from All Causes, Cardiovascular Disease, and Cancer: A Dose-Response Meta-Analysis. Am. J. Epidemiol. 2014;180:763–775. doi: 10.1093/aje/kwu194. [PubMed] [CrossRef] [Google Scholar]

33. Je Y., Giovannucci E. Coffee Consumption and Total Mortality: A Meta-Analysis of Twenty Prospective Cohort Studies. Br. J. Nutr. 2014;111:1162–1173. doi: 10.1017/S0007114513003814. [PubMed] [CrossRef] [Google Scholar]

34. Grosso G., Micek A., Godos J., Sciacca S., Pajak A., Martínez-González M.A., Giovannucci E.L., Galvano F. Coffee Consumption and Risk of All-Cause, Cardiovascular, and Cancer Mortality in Smokers and Non-Smokers: A Dose-Response Meta-Analysis. Eur. J. Epidemiol. 2016;31:1191–1205. doi: 10.1007/s10654-016-0202-2. [PubMed] [CrossRef] [Google Scholar]

35. Park S.-Y., Freedman N.D., Haiman C.A., Le Marchand L., Wilkens L.R., Setiawan V.W. Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations. Ann. Intern. Med. 2017;167:228–235. doi: 10.7326/M16-2472. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

36. Gunter M.J., Murphy N., Cross A.J., Dossus L., Dartois L., Fagherazzi G., Kaaks R., Kühn T., Boeing H., Aleksandrova K., et al. Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study. Ann. Intern. Med. 2017;167:236–247. doi: 10.7326/M16-2945. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

37. Grosso G., Stepaniak U., Micek A., Stefler D., Bobak M., Pajak A. Coffee Consumption and Mortality in Three Eastern European Countries: Results from the HAPIEE (Health, Alcohol and Psychosocial Factors In Eastern Europe) Study. Public Health Nutr. 2016;20:82–91. doi: 10.1017/S1368980016001749. [PubMed] [CrossRef] [Google Scholar]

38. Sado J., Kitamura T., Kitamura Y., Liu R., Ando E., Sobue T., Sugawara Y., Matsuo K., Nakayama T., Tsuji I., et al. Coffee Consumption and All-Cause and Cardiovascular Mortality-Three-Prefecture Cohort in Japan. Circ. J. 2019;83:757–766. doi: 10.1253/circj.CJ-18-0618. [PubMed] [CrossRef] [Google Scholar]

39. Dinu M., Pagliai G., Casini A., Sofi F. Mediterranean Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analyses of Observational Studies and Randomised Trials. Eur. J. Clin. Nutr. 2018;72:30–43. doi: 10.1038/ejcn.2017.58. [PubMed] [CrossRef] [Google Scholar]

40. Happonen P., Läärä E., Hiltunen L., Luukinen H. Coffee Consumption and Mortality in a 14-Year Follow-up of an Elderly Northern Finnish Population. Br. J. Nutr. 2008;99:1354–1361. doi: 10.1017/S0007114507871650. [PubMed] [CrossRef] [Google Scholar]

41. Sado J., Kitamura T., Kitamura Y., Sobue T., Nishino Y., Tanaka H., Nakayama T., Tsuji I., Ito H., Suzuki T., et al. Association between Coffee Consumption and All-Sites Cancer Incidence and Mortality. Cancer Sci. 2017;108:2079–2087. doi: 10.1111/cas.13328. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

42. Yu X., Bao Z., Zou J., Dong J. Coffee Consumption and Risk of Cancers: A Meta-Analysis of Cohort Studies. BMC Cancer. 2011;11:96. doi: 10.1186/1471-2407-11-96. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

43. Gonzalez de Mejia E., Ramirez-Mares M.V. Impact of Caffeine and Coffee on Our Health. Trends Endocrinol. Metab. 2014;25:489–492. doi: 10.1016/j.tem.2014.07.003. [PubMed] [CrossRef] [Google Scholar]

44. Yamagata K. Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome Associated Endothelial Dysfunctions? An Assessment of the Current Evidence. Antioxidants. 2018;7:26. doi: 10.3390/antiox7020026. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

45. Gökcen B.B., Şanlier N. Coffee Consumption and Disease Correlations. Crit. Rev. Food Sci. Nutr. 2019;59:336–348. doi: 10.1080/10408398.2017.1369391. [PubMed] [CrossRef] [Google Scholar]

46. Penolazzi B., Natale V., Leone L., Russo P.M. Individual Differences Affecting Caffeine Intake. Analysis of Consumption Behaviours for Different Times of Day and Caffeine Sources. Appetite. 2012;58:971–977. doi: 10.1016/j.appet.2012.02.001. [PubMed] [CrossRef] [Google Scholar]

47. Machado-Fragua M.D., Struijk E.A., Graciani A., Guallar-Castillon P., Rodríguez-Artalejo F., Lopez-Garcia E. Coffee Consumption and Risk of Physical Function Impairment, Frailty and Disability in Older Adults. Eur. J. Nutr. 2019;58:1415–1427. doi: 10.1007/s00394-018-1664-7. [PubMed] [CrossRef] [Google Scholar]

Articles from Nutrients are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

koffie, ouder worden, overlijden aan alle oorzaken, overlijden aan kanker